It was actually supposed to come last week, but apparently it was not supposed to be presented at the same time as the US election: the recommendation of the Standing Vaccination Commission of the Robert Koch Institute, the Leopoldina and the German Ethics Council, who would be the first to receive an approved vaccine in Germany should.
A corresponding recommendation should come this Monday at 11 a.m. According to NewsABC.net, three groups should be given priority and should receive an approved vaccine first: First, people who are older than 75 years and have chronic diseases such as the heart or respiratory tract.
Then the age groups under 75 with chronic diseases are to be vaccinated step by step. Finally, there are health workers who look after the respective people directly: doctors, nursing staff and hospital staff, but also police officers, teachers and educators.
5 to 10 million vaccine doses in the first delivery
In government circles, it is expected that the first five to ten million vaccine doses for Germany will be available at the end of this or the beginning of next year.
The European Medicines Agency (EMA) is already in an accelerated approval process for two potential vaccines: AZD1222 from AstraZeneca and the University of Oxford and BNT162b2 from Biontech and Pfizer. Once their effectiveness and safety have been proven, approval can be granted.
Whether the amount is then sufficient to actually vaccinate all people in the three recommended groups – especially in parallel – remains unclear. That depends, for example, on whether you have to give the vaccine twice, which is only clear after all clinical tests have been completed.
Nevertheless, the preparations for the vaccinations of the rest of the population are already under way. According to information from NewsABC.net, a meeting is planned for November 13th between Health Minister Jens Spahn (CDU) and the Association of Statutory Health Insurance Physicians (KV) of the federal states, at which details will be discussed on how the population can be supplied with a possible vaccine.
According to information from NewsABC.net, the Bundeswehr, among other things, is being used, which is expected to deliver the approved vaccine to up to 60 locations across Germany.
Vaccine is to be stored at 60 locations
Which locations these are is so far secret. According to the paper, the locations should be communicated to the federal government in a binding manner no later than November 10th. Warehouses, for example on exhibition grounds, are conceivable.
According to the current state of knowledge, the vaccine must then be stored at temperatures as low as minus 80 degrees during transport and at the locations – but cooling at two to eight degrees for five days may also be possible, as initial data on the vaccine from Biontech suggest. That would make transport, storage and inoculation much easier. It is still unclear whether the means will also be guarded by the Bundeswehr or private security services.
The vaccine will then presumably be administered to the population in vaccination centers that the countries are responsible for setting up. People get appointments through the KVen appointment service points, and appropriate IT solutions are currently being developed. In addition, mobile vaccination teams have also been planned so far. In principle, the following applies: the federal government procures and pays for the vaccine, the federal states take care of storage and vaccination – including cannulas and syringes.